UK NEQAS Antimicrobial Susceptibility Quality Assessment (published 22 September 2020)

Re-issued CAN to correct the CF Contract Award Notice for PHE - Corporate - UK NEQAS Antimicrobial. Amended to reflect the Maximum Term and Contract Value as advertised and stated in the tender documents as the original CAN mistakenly only declared the term and value relating to the initial term not the maximum possible, including potential extensions. The contract will be for an initial 3 year period with the options for the Contracting Authority to extend for up to two further periods of 1 year (+1+1). The maximum value of the procurement (excluding VAT): £42,000 Public Health England (PHE) now UKHSA required a supplier to provide expert commentary on bacterial resistance profile to antibiotics and the genetic mechanism they use to become resistant to these antibiotics. Link to previous CF Contract Award Notice: https://www.contractsfinder.service.gov.uk/notice/63d3c2a0-1658-4a26-8a69-2d4e66203213?origin=SearchResults&p=1